Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.

Mas A, Rodés J, Sunyer L, Rodrigo L, Planas R, Vargas V, Castells L, Rodríguez-Martínez D, Fernández-Rodríguez C, Coll I, Pardo A; Spanish Association for the Study of the Liver Hepatic Encephalopathy Cooperative Group.

J Hepatol. 2003 Jan;38(1):51-8.

PMID:
12480560
2.
3.

Rifaximin for the treatment of hepatic encephalopathy.

Lawrence KR, Klee JA.

Pharmacotherapy. 2008 Aug;28(8):1019-32. doi: 10.1592/phco.28.8.1019. Review.

PMID:
18657018
4.

Rifaximin for treatment of hepatic encephalopathy.

Maclayton DO, Eaton-Maxwell A.

Ann Pharmacother. 2009 Jan;43(1):77-84. doi: 10.1345/aph.1K436. Epub 2008 Dec 17. Review.

PMID:
19092143
5.

Rifaximin: new therapeutic indication and future directions.

Rivkin A, Gim S.

Clin Ther. 2011 Jul;33(7):812-27. doi: 10.1016/j.clinthera.2011.06.007. Epub 2011 Jul 7. Review.

PMID:
21741091
6.

Rifaximin for the treatment of hepatic encephalopathy.

de Melo RT, Charneski L, Hilas O.

Am J Health Syst Pharm. 2008 May 1;65(9):818-22. doi: 10.2146/ajhp070298. Review.

PMID:
18436728
7.

Disaccharides in the treatment of hepatic encephalopathy.

Sharma P, Sharma BC.

Metab Brain Dis. 2013 Jun;28(2):313-20. doi: 10.1007/s11011-013-9392-4. Epub 2013 Mar 2. Review.

PMID:
23456517
8.

Treatment options for hepatic encephalopathy.

Schiano TD.

Pharmacotherapy. 2010 May;30(5 Pt 2):16S-21S. doi: 10.1592/phco.30.pt2.16S. Review.

PMID:
20412036
9.

Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.

Eltawil KM, Laryea M, Peltekian K, Molinari M.

World J Gastroenterol. 2012 Feb 28;18(8):767-77. doi: 10.3748/wjg.v18.i8.767. Review.

10.

Management of hepatic encephalopathy: focus on antibiotic therapy.

Festi D, Vestito A, Mazzella G, Roda E, Colecchia A.

Digestion. 2006;73 Suppl 1:94-101. Epub 2006 Feb 8. Review.

PMID:
16498257
11.

Combination therapy for the treatment and prevention of hepatic encephalopathy.

Mohammad RA, Regal RE, Alaniz C.

Ann Pharmacother. 2012 Nov;46(11):1559-63. doi: 10.1345/aph.1R146. Epub 2012 Oct 23. Review.

PMID:
23092866
12.

Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.

Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L.

Eur J Gastroenterol Hepatol. 2008 Nov;20(11):1064-70. doi: 10.1097/MEG.0b013e328302f470. Review.

PMID:
19047837
13.

[Hepatic encephalopathy and liver transplantation].

Fehérvári I, Nemes B, Görög D, Gerlei Z, Kóbori L.

Magy Seb. 2012 Apr;65(2):58-62. doi: 10.1556/MaSeb.65.2012.2.4. Review. Hungarian.

PMID:
22512880
14.

Nonabsorbable disaccharides for hepatic encephalopathy.

Als-Nielsen B, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2004;(2):CD003044. Review.

PMID:
15106187
15.

Hepatic encephalopathy: pathophysiology and emerging therapies.

Sundaram V, Shaikh OS.

Med Clin North Am. 2009 Jul;93(4):819-36, vii. doi: 10.1016/j.mcna.2009.03.009. Review.

PMID:
19577116
16.

Pharmacotherapy for hepatic encephalopathy.

Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A.

Drugs. 2010 Jun 18;70(9):1131-48. doi: 10.2165/10898630-000000000-00000. Review.

PMID:
20518580
17.

Management of hepatic encephalopathy in the hospital.

Leise MD, Poterucha JJ, Kamath PS, Kim WR.

Mayo Clin Proc. 2014 Feb;89(2):241-53. doi: 10.1016/j.mayocp.2013.11.009. Epub 2014 Jan 8. Review.

18.

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Als-Nielsen B, Gluud LL, Gluud C.

BMJ. 2004 May 1;328(7447):1046. Epub 2004 Mar 30. Review.

19.

Review article: the current pharmacological therapies for hepatic encephalopathy.

Bass NM.

Aliment Pharmacol Ther. 2007 Feb;25 Suppl 1:23-31. Review.

20.

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Vilstrup H.

Metab Brain Dis. 2013 Jun;28(2):221-5. doi: 10.1007/s11011-012-9372-0. Epub 2012 Dec 29. Review.

PMID:
23275147
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk